Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gazengel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1994
Evaluation of desmopressin for dental extractions in patients with hemostatic disordersJ Saulnier, A Marey, M H Horellou, et al.
European Journal of Clinical Investigation|December 1, 1987
Monoclonal anti-HBs antibodies radioimmunoassay and serum HBV-DNA hybridization as diagnostic tools of HBV infection: relative prevalence among HBsAg-negative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donorsS Pol, V Thiers, B Nalpas, et al.
The New England Journal of Medicine|October 29, 1987
Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importanceJ P Allain, Y Laurian, D A Paul, et al.
Thrombosis and Haemostasis|July 15, 2000
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study GroupT C Abshire, H H Brackmann, I Scharrer, et al.
Annals of Internal Medicine|April 1, 1985
Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacsC Rouzioux, F Brun-Vezinet, A M Couroucé, et al.
Lancet (London, England)|April 7, 1984
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDSE Vilmer, F Barre-Sinoussi, C Rouzioux, et al.
Human Genetics|April 1, 1993
Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counselingD Vidaud, M Tartary, J M Costa, et al.
Thrombosis and Haemostasis|December 8, 1998
French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune toleranceC Rothschild, Y Laurian, E P Satre, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oral Surgery, Oral Medicine, and Oral Pathology|January 1, 1994
Evaluation of desmopressin for dental extractions in patients with hemostatic disordersJ Saulnier, A Marey, M H Horellou, et al.
European Journal of Clinical Investigation|December 1, 1987
Monoclonal anti-HBs antibodies radioimmunoassay and serum HBV-DNA hybridization as diagnostic tools of HBV infection: relative prevalence among HBsAg-negative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donorsS Pol, V Thiers, B Nalpas, et al.
The New England Journal of Medicine|October 29, 1987
Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importanceJ P Allain, Y Laurian, D A Paul, et al.
Thrombosis and Haemostasis|July 15, 2000
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study GroupT C Abshire, H H Brackmann, I Scharrer, et al.
Annals of Internal Medicine|April 1, 1985
Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacsC Rouzioux, F Brun-Vezinet, A M Couroucé, et al.
Lancet (London, England)|April 7, 1984
Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDSE Vilmer, F Barre-Sinoussi, C Rouzioux, et al.
Human Genetics|April 1, 1993
Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counselingD Vidaud, M Tartary, J M Costa, et al.
Thrombosis and Haemostasis|December 8, 1998
French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune toleranceC Rothschild, Y Laurian, E P Satre, et al.
Pageof 3